abstract |
(57) [Summary]nThe present invention includes the use of a therapeutically effective amount of a compound having Formula I or a pharmaceutically acceptable salt thereof, in a host comprising herpes simplex virus, varicella-zoster virus, respiratory syncytial virus and cytomegalovirus. The present invention relates to uses and methods for treating or preventing a viral infection selected from viruses. The present invention also includes pharmaceutical compositions and combinations. |